首页 | 本学科首页   官方微博 | 高级检索  
     


The ethical assessment of innovative therapies: Liver transplantation using living donors
Authors:Peter A. Singer  Mark Siegler  John D. Lantos  Jean C. Emond  Peter F. Whitington  J. Richard Thistlethwaite  Christoph E. Broelsch
Affiliation:1. Center for Clinical Medical Ethics, The University of Chicago Hospitals, 5841 South Maryland Avenue, 60637, Chicago, IL, USA
2. Department of Pediatrics, The University of Chicago Hospitals, 5841 South Maryland Avenue, 60637, Chicago, IL, USA
3. Department of Surgery, The University of Chicago Hospitals, 5841 South Maryland Avenue, 60637, Chicago, IL, USA
4. Department of Medicine, The University of Chicago Hospitals, 5841 South Maryland Avenue, 60637, Chicago, IL, USA
Abstract:Liver transplantation is the treatment of choice for many forms of liver disease. Unfortunately, the scarcity of cadaveric donor livers limits the availability of this technique. To improve the availability of liver transplantation, surgeons have developed the capability of removing a portion of liver from a live donor and transplanting it into a recipient. A few liver transplants using living donors have been performed worldwide. Our purpose was to analyze the ethics of liver transplants using living donors and to propose guidelines for the procedure before it was introduced in the United States. We used a process of “research ethics consultation” that involves a collaboration between clinical investigators and clinical ethicists. We concluded that it was ethically appropriate to perform liver transplantation using living donors in a small series of patients on a trial basis, and we published our ethical guidelines in a medical journal before the procedure was introduced. We recommend this prospective, public approach for the introduction of other innovative therapies in medicine and surgery.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号